Skip to main content
OICS v0.4.1 class · Healthcare

Commercial Biotech

ID CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, new substances it discovered, in-licensed or acquired, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more. Approved new formulations of approved substances -> HC.PH.PHA.GNX.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: every company classified here, including delisted companies and companies without filings.

Company Ticker Country Market cap Filings
Zai Lab Ltd ZLAB United States of America $2.02Bas of 1 Apr 2026 1,222
Aurinia Pharmaceuticals Inc. AUPH Canada $2.01Bas of 7 Jul 2026 670
ANAPTYSBIO, INC ANAB United States of America $1.97Bas of 13 Jul 2026 751
Zymeworks Inc. ZYME United States of America $1.96Bas of 10 Jul 2026 436
Ultragenyx Pharmaceutical Inc. RARE United States of America $1.90Bas of 31 Mar 2026 1,196
Viridian Therapeutics, Inc.\DE VRDN United States of America $1.89Bas of 31 Mar 2026 878
Vericel Corp VCEL United States of America $1.85Bas of 8 Jun 2026 1,712
DYNAVAX TECHNOLOGIES CORP Delisted DVAX United States of America $1.82Bas of 27 Jun 2026 1,627
OCULAR THERAPEUTIX, INC OCUL United States of America $1.80Bas of 6 Jun 2026 918
Syndax Pharmaceuticals Inc SNDX United States of America $1.79Bas of 23 May 2026 795
Idorsia Ltd IDIA Switzerland $1.78Bas of 16 Jul 2026 502
MESOBLAST LTD MESO Australia $1.78Bas of 9 Jul 2026 2,168
Nuvation Bio Inc. NUVB United States of America $1.68Bas of 6 Jun 2026 442
Innoviva, Inc. INVA United States of America $1.66Bas of 29 Mar 2026 1,605
Harmony Biosciences Holdings, Inc. HRMY United States of America $1.60Bas of 3 Apr 2026 541
Novavax, Inc. NVAX United States of America $1.46Bas of 13 Jun 2026 1,648
Immunocore Holdings plc IMCR United Kingdom $1.44Bas of 8 Jun 2026 318
KalVista Pharmaceuticals, Inc. KALV United States of America $1.44Bas of 9 Jun 2026 909
Oncolys BioPharma Inc. 4588 Japan $1.38B 783
ARDELYX, INC. ARDX United States of America $1.34Bas of 30 Mar 2026 1,191
UroGen Pharma Ltd. URGN Israel $1.33Bas of 10 Jun 2026 638
Pharma Mar S.A. PHM Spain $1.32Bas of 22 Jun 2026 408
Precigen, Inc. PGEN United States of America $1.28Bas of 8 Jun 2026 1,270
MANNKIND CORP MNKD United States of America $1.10Bas of 11 Jun 2026 2,078
MedinCell S.A. MEDCL France $1.07Bas of 13 Jul 2026 647
LEXICON PHARMACEUTICALS, INC. LXRX United States of America $986.12Mas of 13 Jul 2026 1,398
GERON CORP GERN United States of America $967.22Mas of 25 Mar 2026 1,570
Nxera Pharma Co., Ltd. 4565 Japan $964.72M 967
Pharming Group N.V. PHARM Netherlands $953.07Mas of 6 Jul 2026 1,075
ALLERGY THERAPEUTICS PLC AGY United Kingdom $853.46Mas of 7 Apr 2026 422
Phathom Pharmaceuticals, Inc. PHAT United States of America $825.02Mas of 26 Mar 2026 548
Basilea Pharmaceutica AG BSLN Switzerland $822.66Mas of 1 Apr 2026 528
Theravance Biopharma, Inc. Delisted TBPH United States of America $785.78Mas of 1 Apr 2026 1,166
OMEROS CORP OMER United States of America $744.02Mas of 19 Jun 2026 828
ONENESS BIOTECH CO., LTD. 4743 Taiwan $740.62Mas of 2 Jun 2026 2,196
Kura Oncology, Inc. KURA United States of America $718.12Mas of 1 Apr 2026 842
Esperion Therapeutics, Inc. ESPR United States of America $703.66Mas of 2 Apr 2026 1,024
Sinovac Biotech Ltd. SVA Antigua and Barbuda $642.44Mas of 2 Apr 2026 582
IRONWOOD PHARMACEUTICALS INC IRWD United States of America $597.55Mas of 12 Jun 2026 1,465
Rigel Pharmaceuticals, Inc. RIGL United States of America $568.38Mas of 11 Jun 2026 1,479
GENFIT GNFT France $558.19Mas of 29 Jun 2026 979
ZEVRA THERAPEUTICS, INC. ZVRA United States of America $547.19Mas of 1 Apr 2026 916
Valneva SE VLA France $466.93Mas of 3 Jul 2026 1,924
TaiMed Biologics Inc. 4147 Taiwan $461.61Mas of 11 Jun 2026 2,061
Emergent BioSolutions Inc. EBS United States of America $406.40Mas of 8 Apr 2026 1,768
ABEONA THERAPEUTICS INC. ABEO United States of America $402.39Mas of 17 Jul 2026 1,294
Enanta Pharmaceuticals, Inc. ENTA United States of America $398.37Mas of 13 Jul 2026 884
SanBio Company Limited 4592 Japan $390.43M 867
X4 Pharmaceuticals, Inc XFOR United States of America $385.50Mas of 7 Apr 2026 854
Verastem, Inc. VSTM United States of America $375.22Mas of 23 May 2026 1,095

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

No aliases listed.

Not here
Clinical-Stage Biotech CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Also preclinical, drug developer

https://financialfilings.com/oics/CMB/

This page is keyed by the class ID CMB. IDs freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard